PortfoliosLab logoPortfoliosLab logo
ETON vs. ARKF
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ETON vs. ARKF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eton Pharmaceuticals Inc (ETON) and ARK Fintech Innovation ETF (ARKF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ETON achieves a 174.51% return, which is significantly higher than ARKF's -16.75% return.


ETON

1D
-5.32%
1M
23.79%
6M
209.26%
YTD
174.51%
1Y
228.52%
3Y*
154.38%
5Y*
55.29%
10Y*
ALL TIME*
29.32%

ARKF

1D
-2.10%
1M
-3.22%
6M
-8.41%
YTD
-16.75%
1Y
-22.13%
3Y*
18.55%
5Y*
-4.77%
10Y*
ALL TIME*
9.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$6.49M$5.67M$7.32M
$26.85M$22.65M$16.80M

ETON vs. ARKF - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
ETON
Eton Pharmaceuticals Inc
174.51%26.95%204.11%55.32%-34.27%-47.23%12.92%10.88%
ARKF
ARK Fintech Innovation ETF
-16.75%28.67%34.34%93.27%-65.07%-17.82%108.03%20.45%

Correlation

The correlation between ETON and ARKF is 0.20, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.20

Correlation (3Y)
Balances recent behavior with more history.

0.24

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.30

Correlation (All Time)
Calculated using the full available price history since Feb 4, 2019

0.30

The correlation between ETON and ARKF shifts across timeframes, from 0.20 (1 year) to 0.30 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ETON vs. ARKF — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ETON
ETON Risk / Return Rank: 9797
Overall Rank
ETON Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
ETON Sortino Ratio Rank: 9797
Sortino Ratio Rank
ETON Omega Ratio Rank: 9797
Omega Ratio Rank
ETON Calmar Ratio Rank: 9797
Calmar Ratio Rank
ETON Martin Ratio Rank: 9494
Martin Ratio Rank

ARKF
ARKF Risk / Return Rank: 44
Overall Rank
ARKF Sharpe Ratio Rank: 33
Sharpe Ratio Rank
ARKF Sortino Ratio Rank: 44
Sortino Ratio Rank
ARKF Omega Ratio Rank: 44
Omega Ratio Rank
ARKF Calmar Ratio Rank: 44
Calmar Ratio Rank
ARKF Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ETON vs. ARKF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ETONARKFDifference
Sharpe ratioReturn per unit of total volatility

+4.89

Sortino ratioReturn per unit of downside risk

+5.16

Omega ratioGain probability vs. loss probability

1.55

0.89

+0.66

Calmar ratioReturn relative to maximum drawdown

6.34

-0.68

+7.02

Martin ratioReturn relative to average drawdown

13.13

-1.10

+14.23

ETON vs. ARKF - Sharpe Ratio Comparison

The current ETON Sharpe Ratio is 4.12, which is higher than the ARKF Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of ETON and ARKF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ETON vs. ARKF - Drawdown Comparison

The maximum ETON drawdown since its inception was -79.94%, roughly equal to the maximum ARKF drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for ETON and ARKF.


Loading charts...

Drawdown Indicators


ETONARKFDifference

Max Drawdown

Largest peak-to-trough decline

-79.94%

-78.63%

-1.31%

Max Drawdown (1Y)

Largest decline over 1 year

-36.17%

-38.50%

+2.33%

Max Drawdown (3Y)

Largest decline over 3 years

-45.65%

-38.50%

-7.15%

Max Drawdown (5Y)

Largest decline over 5 years

-69.35%

-75.30%

+5.95%

Current Drawdown

Current decline from peak

-5.32%

-37.60%

+32.28%

Average Drawdown

Average peak-to-trough decline

-36.98%

-34.98%

-2.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.44%

23.82%

-6.38%

Volatility

ETON vs. ARKF - Volatility Comparison

Eton Pharmaceuticals Inc (ETON) has a higher volatility of 20.28% compared to ARK Fintech Innovation ETF (ARKF) at 8.29%. This indicates that ETON's price experiences larger fluctuations and is considered to be riskier than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ETONARKFDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.28%

8.29%

+11.99%

Volatility (6M)

Calculated over the trailing 6-month period

43.44%

26.23%

+17.21%

Volatility (1Y)

Calculated over the trailing 1-year period

55.80%

34.01%

+21.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

63.59%

42.99%

+20.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.81%

39.63%

+24.18%

Dividends

ETON vs. ARKF - Dividend Comparison

ETON has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.11%.


PositionTTM2025202420232022202120202019
ARKF
ARK Fintech Innovation ETF
0.11%0.09%0.00%0.00%0.00%0.00%0.37%1.25%
ETON
Eton Pharmaceuticals Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


ETON and ARKF have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ETON has higher volatility (20.28%) compared to ARKF (8.29%). In terms of maximum drawdown, ETON dropped -79.94% vs ARKF's -78.63%.

ETON currently has the higher Sharpe Ratio (4.12 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ETON and ARKF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer